Cross-Sector entity
AI is the most frequent co-covered peer, appearing in 4 of the 7 tracked stories. The 140-day window averages about 0.4 stories each week. The busiest single day carried 5. The clearest coverage concentration is earnings: 2 of 7 stories, with the rest divided among 5 other categories.
7 verified stories tracked
Last mentioned: Aug 7, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
AI is the most frequent co-covered peer, appearing in 4 of the 7 tracked stories. The 140-day window averages about 0.4 stories each week. The busiest single day carried 5. The clearest coverage concentration is earnings: 2 of 7 stories, with the rest divided among 5 other categories. Each carries 2 original sources on average. Akamai Technologies appears in 7 tracked Cross-Sector stories published from March 21, 2026 through August 7, 2026. Negative sentiment appears in 0% of the tracked stories.
Computed from the 7 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Akamai Technologies. Shared-story counts are live from our verified record — not editorial picks.
Akamai and AvePoint report Q2 2026 earnings
Both companies released their quarterly results, highlighting AI-driven demand for infrastructure and security.
AvePoint launches standalone AgentPulse product
AgentPulse, previously bundled in the Control suite, became available as a standalone product to provide visibility into AI agent ownership, permissions, and costs.
Akamai Technologies boosted its full-year EPS guidance far above analyst estimates, but shares fell 3% as revenue guidance merely met expectations and valuation concerns weighed. The Q2 earnings beat and strong balance sheet provide support, yet the rich P/E and moderate growth rate leave investors cautious.
Source: MarketBeat · tickerreport.com
The Q2 earnings of AvePoint and Akamai reveal two sides of enterprise AI: AvePoint’s survey found 88% of IT leaders hit by AI agent security incidents, while Akamai landed a $600 million cloud infrastructure deal for robotics development. Both signal a maturing but chaotic AI market.
AvePoint's SaaS revenue surged 27% to $98.5 million, now 79% of total, while Akamai's cloud infrastructure revenue rose 5% and its multi-year commitments swelled to $2.8 billion. The Q2 results underscore diverging SaaS and IaaS models in the AI era.
Akamai Technologies locked in over $2.8 billion in multi-year cloud commitments in 2026 so far, while AvePoint's ARR jumped 27% to $465.1 million. Both companies' Q2 results highlight how AI infrastructure and governance are reshaping growth and margin profiles.
AvePoint's Q2 survey revealed 88% of 750 IT leaders suffered AI agent security incidents, just as Akamai ramps cloud infrastructure to power AI workloads. Both companies' earnings show surging demand for security and governance in an era of agent sprawl.
Source: MarketBeat · themarketsdaily.com
Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, signaling a shift away from the underperforming medical device maker. The exit comes as Haemonetics shares have lagged the broader market, dropping 9% over the past year while the fund rotates capital into diversified healthcare and technology plays.
Invenomic Capital Management has fully liquidated its $24.29 million position in Haemonetics Corporation, a leader in blood and plasma management technology. The exit comes as the stock underperformed the broader market by 25% over the past year, signaling a shift in institutional sentiment toward the medical device sector.
Source: Jonathan Ponciano (us) · fool.com
